PREVIEW: Merck & Co Inc (MRK) earnings due 03/Feb at 11:30GMT/06:30EST

Merck & Co Inc (MRK) Q4 2021 (USD): EPS (exp. 1.53/1.33 GAAP), Revenue (exp. 13.16bln)

KEY PHARMA SALES:

REVENUE SEGMENTS:

DIVIDEND:

EPS GUIDANCE:

REVENUE GUIDANCE:

INDEX WEIGHT:

BROKER RATING:

02 Feb 2022 - 17:00- Equities- Source: Newsquawk

PharmaceuticalsPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals (Group)Merck & Co IncEquitiesS&P 500 IndexGermanyMRKMRK.USMerck KGaADAX 40 IndexEuropeKEYBanksBanks (Group)KeyCorpDiversified BanksUSDAsian SessionUnited States

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: